Charite - University Medicine Berlin: Plasma Cells at the Center of a Novel Treatment Approach
September 23, 2020
September 23, 2020
BERLIN, Germany, Sept. 23 (TNSJou) -- Charite - University Medicine Berlin issued the following news:
A team of researchers from Charite - Universitatsmedizin Berlin and the Deutsches Rheuma-Forschungszentrum (DRFZ) Berlin, a Leibniz Institute, have successfully treated two patients with the autoimmune disease systemic lupus erythematosus. Using daratumumab, a monoclonal antibody which targets specific immune cells known as plasma cells, the researchers were able to modulate the abn . . .
A team of researchers from Charite - Universitatsmedizin Berlin and the Deutsches Rheuma-Forschungszentrum (DRFZ) Berlin, a Leibniz Institute, have successfully treated two patients with the autoimmune disease systemic lupus erythematosus. Using daratumumab, a monoclonal antibody which targets specific immune cells known as plasma cells, the researchers were able to modulate the abn . . .